The differential diagnosis of renal failure associated with hypocomplementemia includes lupus nephritis, mixed cryoglobulinemia, idiopathic membranoproliferative glomerulonephritis (MPGN), and ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

People with AFib have many treatment options, including medications and medical procedures. However, there are natural and alternative treatments that you may discuss with your healthcare team to ...

This sale was conducted to cover tax withholding obligations related to the release of Restricted Stock Units on January 21, 2025. According to InvestingPro analysis, which offers comprehensive ...

Window treatments can make or break the overall look of a room, so it's important to get them right. Like any decor, curtain trends come and go, so if you have any of these once-popular window ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Other common causes include Haemophilus influenzae, Chlamydia pneumoniae, and Mycoplasma pneumoniae. Antibiotic drugs, which treat bacterial infections, are the primary form of treatment for bacterial ...

The exact cause of ALS remains unknown, and currently, there is no cure. The treatment options for ALS are limited, focusing primarily on slowing disease progression and managing symptoms. The ...

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional radiotherapy. It also takes less than a second. In a series of vast underground ...

Recent developments include the planned submission of a supplemental new drug application for EMPAVELI® for the treatment ... M-associated membranoproliferative glomerulonephritis, with a ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

Iptacopan (LNP-023) is under development for the treatment of myasthenia gravis, glomerulonephritis- IgA nephropathy (Berger's disease), early to middle age-related macular degeneration, C3 ...